- Home
- VPG vs ATAI Comparison
VPG vs ATAI Comparison
Compare VPG & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VPG
- ATAI
- Stock Information
- Founded
- VPG 2009
- ATAI 2018
- Country
- VPG United States
- ATAI Germany
- Employees
- VPG N/A
- ATAI N/A
- Industry
- VPG Electrical Products
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- VPG Technology
- ATAI Health Care
- Exchange
- VPG Nasdaq
- ATAI Nasdaq
- Market Cap
- VPG 293.3M
- ATAI 271.6M
- IPO Year
- VPG N/A
- ATAI 2021
- Fundamental
- Price
- VPG $23.48
- ATAI $1.52
- Analyst Decision
- VPG Hold
- ATAI Strong Buy
- Analyst Count
- VPG 1
- ATAI 4
- Target Price
- VPG $31.00
- ATAI $9.00
- AVG Volume (30 Days)
- VPG 75.8K
- ATAI 1.8M
- Earning Date
- VPG 05-06-2025
- ATAI 03-17-2025
- Dividend Yield
- VPG N/A
- ATAI N/A
- EPS Growth
- VPG N/A
- ATAI N/A
- EPS
- VPG 0.74
- ATAI N/A
- Revenue
- VPG $306,522,000.00
- ATAI $308,000.00
- Revenue This Year
- VPG $2.60
- ATAI N/A
- Revenue Next Year
- VPG $6.04
- ATAI $20.00
- P/E Ratio
- VPG $30.92
- ATAI N/A
- Revenue Growth
- VPG N/A
- ATAI N/A
- 52 Week Low
- VPG $20.83
- ATAI $0.78
- 52 Week High
- VPG $35.52
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- VPG 55.69
- ATAI 50.35
- Support Level
- VPG $22.16
- ATAI $1.37
- Resistance Level
- VPG $24.39
- ATAI $1.48
- Average True Range (ATR)
- VPG 0.69
- ATAI 0.10
- MACD
- VPG 0.18
- ATAI 0.02
- Stochastic Oscillator
- VPG 75.68
- ATAI 79.71
About VPG Vishay Precision Group Inc.
Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.